CLOUGH CAPITAL PARTNERS L P – CRISPR Therapeutics AG Transaction History
CLOUGH CAPITAL PARTNERS L P portfolio value:
$27.10M
portfolio value
CLOUGH CAPITAL PARTNERS L P quarter portfolio value change:
+7.54%
quarter
CRISPR Therapeutics AG 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +30.73% | 97.5K shares | 7.82M | $65.35 | 414.76K |
| Q2 2022 | share | Increase | +53.93% | 111.16K shares | 6.34M | $60.77 | 317.26K |
| Q1 2022 | call | Decrease | -100.00% | -80.8K shares | -6.12M | $62.77 | 0 |
| Q1 2022 | share | Increase | +94.43% | 100.1K shares | 4.90M | $62.77 | 206.10K |
| Q4 2021 | call | Increase | 0.00% | 80.8K shares | 6.12M | $78.85 | 80.8K |
| Q4 2021 | share | Decrease | -24.98% | -35.3K shares | -7.78M | $78.85 | 106.00K |
| Q3 2021 | share | Decrease | -18.40% | -31.86K shares | -12.21M | $111.93 | 141.30K |
| Q3 2021 | call | Decrease | -100.00% | -242.5K shares | -39.25M | $111.93 | 0 |
| Q2 2021 | call | Increase | +122.48% | 133.5K shares | 25.97M | $161.89 | 242.5K |
| Q2 2021 | share | Decrease | -7.39% | -13.81K shares | 5.25M | $161.89 | 173.16K |
| Q1 2021 | call | Increase | 0.00% | 109K shares | 13.28M | $121.85 | 109K |
| Q1 2021 | share | Increase | +28.94% | 41.97K shares | 581K | $121.85 | 186.97K |
| Q4 2020 | share | Decrease | -45.66% | -121.82K shares | -115K | $153.11 | 145.00K |
| Q3 2020 | call | Decrease | -100.00% | -97.3K shares | -7.15M | $83.64 | 0 |
| Q3 2020 | share | Decrease | -10.17% | -30.2K shares | 488K | $83.64 | 266.82K |
| Q2 2020 | call | Decrease | -52.86% | -109.1K shares | -1.60M | $73.49 | 97.3K |
| Q2 2020 | share | 0.00% | 0 shares | 9.23M | $73.49 | 297.02K | |
| Q1 2020 | call | Increase | 0.00% | 206.4K shares | 8.75M | $42.41 | 206.4K |
| Q1 2020 | share | Decrease | -33.24% | -147.9K shares | -14.50M | $42.41 | 297.02K |
| Q4 2019 | call | Decrease | -100.00% | -93.9K shares | -3.84M | $60.91 | 0 |
| Q4 2019 | share | Decrease | -7.27% | -34.87K shares | 7.43M | $60.91 | 444.92K |
| Q3 2019 | call | Decrease | -39.81% | -62.1K shares | -3.49M | $40.99 | 93.9K |
| Q3 2019 | share | Increase | +8.72% | 38.5K shares | -1.11M | $40.99 | 479.80K |
| Q2 2019 | share | Decrease | -23.95% | -138.96K shares | 58K | $47.1 | 441.30K |
| Q2 2019 | call | Increase | 0.00% | 156K shares | 7.34M | $47.1 | 156K |
| Q1 2019 | share | Increase | +12.44% | 64.2K shares | 5.98M | $35.72 | 580.26K |
| Q4 2018 | share | Increase | +52.80% | 178.33K shares | -234K | $28.57 | 516.06K |
| Q3 2018 | share | Decrease | -11.78% | -45.1K shares | -7.51M | $44.35 | 337.73K |
| Q2 2018 | share | Decrease | -31.67% | -177.4K shares | -3.11M | $58.76 | 382.83K |
| Q1 2018 | share | Decrease | -37.10% | -330.4K shares | 4.69M | $45.71 | 560.23K |
| Q4 2017 | share | Increase | +14.19% | 110.7K shares | 6.97M | $23.48 | 890.63K |
| Q3 2017 | share | Decrease | -2.17% | -17.3K shares | 1.16M | $17.87 | 779.93K |
| Q2 2017 | share | Decrease | -3.35% | -27.63K shares | -5.14M | $16.02 | 797.23K |
| Q1 2017 | share | Decrease | -1.66% | -13.92K shares | 1.24M | $21.77 | 824.86K |
| Q4 2016 | share | Increase | 0.00% | 838.79K shares | 16.67M | $20.26 | 838.79K |